Header

UZH-Logo

Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 5.

Happold, C; Gorlia, T; Chinot, O; Gilbert, M R; Nabors, L B; Wick, W; Pugh, S L; Hegi, M; Cloughesy, T; Roth, P; Reardon, D A; Perry, J R; Mehta, M P; Stupp, R; Weller, M (2016). Reply to F. Felix et al and M.F. Fay et al. Journal of Clinical Oncology, 34(25):3107-3108.

Happold, C; Gorlia, T; Chinot, O; Gilbert, M R; Nabors, L B; Wick, W; Pugh, S L; Hegi, M; Cloughesy, T; Roth, P; Reardon, D A; Perry, J R; Mehta, M P; Stupp, R; Weller, M (2016). Does Valproic Acid or Levetiracetam Improve Survival in Glioblastoma? A Pooled Analysis of Prospective Clinical Trials in Newly Diagnosed Glioblastoma. Journal of Clinical Oncology, 34(7):731-739.

Okada, H; Weller, M; Huang, R; Finocchiaro, G; Gilbert, M R; Wick, W; Ellingson, B M; Hashimoto, N; Pollack, I F; Brandes, Al A; Franceschi, E; Herold-Mende, C; Nayak, L; Panigrahy, A; Pope, W B; Prins, R; Sampson, J H; Wen, P Y; Reardon, D A (2015). Immunotherapy response assessment in neuro-oncology: a report of the RANO working group. Lancet Oncology, 16(15):e534-e542.

Ellingson, B M; Bendszus, M; Boxerman, J; Barboriak, D; Erickson, B J; Smits, M; Nelson, S J; Gerstner, E; Alexander, B; Goldmacher, G; Wick, W; Vogelbaum, M; Weller, M; Galanis, E; Kalpathy-Cramer, J; Shankar, L; Jacobs, P; Pope, W B; Yang, D; Chung, C; Knopp, M V; Cha, S; van den Bent, M J; Chang, S; Yung, W K; Cloughesy, T F; Wen, P Y; Gilbert, M R (2015). Consensus recommendations for a standardized Brain Tumor Imaging Protocol in clinical trials. Neuro-Oncology, 17(9):1188-1198.

Hegi, M E; Liu, L; Herman, J G; Stupp, R; Wick, W; Weller, M; Mehta, M P; Gilbert, M R (2008). Correlation of O6-methylguanine methyltransferase (MGMT) promoter methylation with clinical outcomes in glioblastoma and clinical strategies to modulate MGMT activity. Journal of Clinical Oncology, 26(25):4189-4199.

This list was generated on Sat Nov 25 06:47:40 2017 CET.